Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06069856 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multiple Micronutrient Supplementation (MMS) vs IFA Acceptability Crossover Trial

Study acronym: MIFA-ACT
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Sep 1, 2026 to Dec 1, 2027
    • Start date: May 1, 2026 to Jun 1, 2027
    • Study completion pushed from Dec 2026 to Dec 2027
    v7
  2. Start date: Jan 2026 to May 1, 2026
    • Primary completion date: Jul 2026 to Sep 1, 2026
    • Study completion date: Jul 2026 to Dec 2026
    v6
  3. Start date: Jun 2025 to Jan 2026
    • Eligibility criteria expanded, about 14 words
    v5
  4. Study Identification, Study Status, Oversight, Contacts/Locationsv4
  5. Primary and study completion dates: Dec 2025 to Jul 2026v3 Show 4 more changesShow less
    • Primary endpoints: 10 to 1
    • Start date: Sep 2025 to Jun 2025
    • Secondary endpoints expanded, about 8 words
    • Study title shortened, about 1 word
  6. Primary endpoints: 18 to 10
    • Eligibility criteria expanded, about 7 words
    • Study title shortened, about 7 words
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an open-label individually randomized mixed methods cross-over trial to assess acceptability, preference, and side effects of IFA formulations with 60 mg of iron to MMS formulations with 60 mg of iron.
Trial Details
NCT Number NCT06069856
Lead Sponsor George Washington University
Collaborators: Ifakara Health Institute, Harvard School of Public Health (HSPH), Muhimbili University of Health and Allied Sciences, Africa Academy for Public Health, Columbia University
Conditions
(from sponsor)		 Pregnancy Related
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov